DavidHGarfieldMD

PubMed

• 28 citations
  Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
  Xiaosong Chen, Siji Zhu, Xiaochun Fei, David H. Garfield, Jiayi Wu
  BMC Cancer. 2015-10-30
• 19 citations
  Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
  Yiliang Zhang, Haichuan Hu, Rui Wang, Ting Ye, Yunjian Pan
  Annals of Surgical Oncology. 2014-08-01
• 14 citations
  Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.
  Ramaswamy Govindan, David Garfield
  Seminars in Oncology. 2004-12-01

Journal Articles

• MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer  
  Li B, Ren S, Li X, Wang Y, Garfield D, et al, Lung Cancer, 11/13/2013
• Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma  
  Li B, Chen H, Xiang J, Zhang Y, Kong Y, Garfield DH, et al, J Thorac Cardiovasc Surg, 8/26/2013
• Practicing Western Oncology in Shanghai, China: One Group's Experience  
  Garfield DH, Brenner HJ, Lu L, J Oncol Pract, 7/1/2013
• Stromal cells in tumor microenvironment and breast cancer  
  Mao Y, Keller ET, Garfield DH, et al, Cancer Metastasis Rev, 1/1/2013
• Does sex affect survival of patients with squamous cell esophageal cancer?  
  Zhang J, Garfield D, Jiang Y, et al, J Clin Oncol, 1/1/2013
• Aytpical histiocytosis in the lung  
  Li H, Cao W, Li H, Zhang R, Zhou Y, Xu J, Garfield DH, J Thorac Dis, 1/1/2013
• Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of non-lymph node thoracic lesions  
  Yang H, Zhao H, Garfield DH, et al, Ann Thorac Med, 1/1/2013
• CYP19A1 gene polymorphism and risk of lung cancer  
  Zhang J, Yin Y, Niu XM, Liu Y, Garfield D, et al, J Int Med Res, 1/1/2013
• Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials  
  Zhang Y, Sun Y, Wang L, Ye T, Pan Y, Hu H, Yu Y, Zhao N, Song Y, Garfield D, Chen H, Onco Targets Ther, 1/1/2013
• Endobronchial ltrasound-guided transbronchial needle aspiration in diagnosing intrathoracic tuberculosis  
  Sun J, Teng J, Yang H, Li Z, Zhang J, Zhao H, Garfield DH, Han B, Ann Thorac Surg, 1/1/2013
• The use of quantitative real-time PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers  
  Wang R, Pan Y, Li C, Hu H, Zhang Y, Li H, Luo X, Zhang J, Fang Z, Li Y, Shen L, Ji H, Garfield D, et al, Clin Cancer Res, 1/1/2012
• RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer  
  Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, Lu Y, Lu Q, Xu J, Garfield D, et al, J Clin Oncol, 1/1/2012
• Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non-small-cell lung cance...  
  Chu TQ, Ding H, Garfield DH, et al, J Thorac Oncol, 1/1/2012
• Thyroid dysfunction in patients treated with sunitinib or sorafenib  
  Clemons J, Gao D, Naam M, Breaker K, Garfield D, et al, Clin Genitourin Cancer, 1/1/2012
• FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells  
  Xu N, Zhang X, Wang X, Ge HY, Wang XY, Garfield D, et al, Acta Pharmacol Sin, 1/1/2012
• Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients treated with first-line, platinum-based chemotherapy  
  Zhao X, Wang X, Wu W, Gao Z, Garfield DH, et al, Cancer, 1/1/2012
• A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced...  
  Carter DL, Garfield D, Hathorn J, et al, Clin Lung Cancer, 1/1/2012
• Cough and hemoptysis in a middle-aged woman  
  Ge H, Garfield D, Ben S, et al, Respiration, 1/1/2012
• Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosis  
  Garfield D, Normanno N, Cadranel J, Lung Cancer, 1/1/2012
• The value of autofluorescence bronchoscopy combined with white light bronchoscopy in the diagnosis of lung cancer: A meta-analysis  
  Sun J, Garfield DH, Lam B, et al, J Thorac Oncol, 1/1/2011
• Dramatic and durable response to pemetrexed in patient with pneumonic-type mucinous bronchioloalveolar carcinoma  
  Garfield DH, J Thorac Oncol, 1/1/2011
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Ad...  
  Travis WD, Brambilla E, Noguchi M, et al, J Thorac Oncol, 1/1/2011
• The importance of distinguishing between mucinous and non-mucinous bronchioloalveolar carcinoma  
  Garfield DH, Cadranel J, Annals of Respiratory Medicine, 1/1/2011
• Osteoblastosis and activating EGFR mutations: a relationship?  
  Garfield D, Normanno N, J Thorac Oncol, 1/1/2010
• Mucinous, nonmucinous bronchioloalveolar carcinoma and smoking  
  Garfield DH, Am J Clin Pathol, 1/1/2010
• Join now to see all

Books/Book Chapters

• Hematology/Oncology Secrets 
  Chapter: "Hodgkin's Disease." 
  Page 146 - 154Garfield DHanley and Belfus, Inc. Medical Publishers1999
• Tumor Board: Cancer Diagnosis and Treatment 
  Chapter: "Hodgkin's Disease in Older Persons." 
  Page 664 - 670Garfield DLippencott-Raven Publishers1997
• Hematology/Oncology Secrets 
  Chapter: "Testicular Cancer." 
  Page 295 - 302Garfield DHanley and Belfus, Inc. Medical Publishers1993

Abstracts/Posters

• Effects of gefitinib (G) on bone metastases (BMs) in non-small cell lung cancer (NSCLC) patients (pts).
  Garfield DH, Zampa G, Cadranel J, et al, American Society of Clinical Oncology, 1/1/2006
• "Phase 2 Trial of Single-Agent, Weekly Docetaxel as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer."
  Canfield V, Garfield D, et al, American Society of Clinical Oncology, 1/1/2002
• "Phase 2 Study of Sequential Chemotherapy Followed by Oral Maintenance Therapy with Orzel (UFT + Leukovorum) in Patients with Stage 3B and 4 Non-Small Cell Lung Cancer."
  Marsland, T, Garfield, D, et al, American Society of Clinical Oncology, 1/1/2002
• "First Line Chemotherapy with Topotecan and Gemcitibine for Patients with Advanced Non-Small Cell Lung Cancer."
  Joppert M, Garfield, D et al, American Society of Clinical Oncology, 1/1/2002
• "Multicenter Phase 2 Trial of Paclitaxel, Ifosfamide and Carboplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer."
  Neubauer M, Garfield D, et al, American Society of Clinical Oncology, 1/1/2002
• "A Phase II Study of Weekly Paclitaxel (Taxol) Followed by Carboplatin and Etoposide in the Treatment of Extensive Small Cell Lung Cancer (SCLC)."
  Ferri W, Garfield D, Neubauer M, et al, American Society of Clinical Oncology, 1/1/2001
• "A Phase II Study of Weekly Paclitaxel (Taxol) in Stage IIIB, IV, or Relapsed After Local Therapy, Non-Small Cell Lung Cancer (NSCLC) Patients with a Performance Statu...
  Marsland T, Garfield D, Khan M, et al, American Society of Clinical Oncology, 1/1/2001
• "A Phase II Study of Weekly Taxol + Paraplatin (Paclitaxel + Carboplatin) in Stage IIIb and Stave IV Non-Small Cell Lung Cancer (NSCLC) Patients Who Have a Performance...
  Marsland T, Garfield D, Khan M, et al, American Society of Clinical Oncology, 1/1/2001
• "Phase II Trial of Weekly Docetaxel (Taxotere) Plus Gemcitabine (Gemzar) as First-Line Therapy for Patients with Advanced Non-Small Cell Lung Cancer (ANSCLC)."
  Neubauer M, Garfield D, Khan M, et al, American Society of Clinical Oncology, 1/1/2001
• "A Gender Related Regimen? Weekly Taxol as Maintenance Therapy (MT) for Patients with Extensive Small Cell Lung Carcinoma (SCLC-ED) Responding to Induction Therapy wit...
  Garfield D, Dakhil S, Asmar L, et al, American Society of Clinical Oncology, 1/1/2000
• "Short-Term Autologous Tumor Cell Lines for the Active Specific Immuno-Therapy of Metastatic Melanoma."
  Dillman R., Barth N, DeLeon C, O'Conner A, Schwartzberg L, Spitler L, Mahdavi K, Garfield D, et al, International Conference on Advanced in Cancer Immunotherapy, 1/1/2000
• "First Line Therapy of Taxotere (T) and Navelbine (N) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase II Study."
  Walls J, O'Rourke M, Garfield D, et al, American Society of Clinical Oncology, 1/1/2000
• "A Phase II Evaluation of Amifostine, Cisplatin, and Etoposide with Hyperfractionated Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer (SCLC-LD)."
  Wasserman T, Garfield D, American Society of Clinical Oncology, 1/1/2000
• "Phase-II Trial of Etoposide (E) and Carboplatin (CP) Induction Therapy (IT) Followed by Weekly Taxol (T) Maintenance Therapy (MT) in Patients with Extensive Stage Sma...
  Garfield D, Dakhil S, Abubakr Y, et al, Journal of the International Association for the Study of Lung Cancer, 9/1/1999
• "Phase II Trial of Taxotere (TXT) and Navelbine (N) as First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (ANSCLC)."
  O'Rourke M, Garfield D, Ellis P, Journal of the International Association for the Study of Lung Cancer, 9/1/1999
• "Phase II Trial of Taxotere (TXT) and Navelbine (N) as First-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (ANSCLC)."
  O'Rourke M, Garfield D, Ellis P, American Society of Clinical Oncology, 1/1/1999
• "Phase II Trial of Carboplatin (CP) and Etoposide (E) Induction Therapy (IT) Followed by Weekly Taxol (T) Maintenance Therapy (MT) in Patients with Extensive Stage Sma...
  Garfield D, Dakhil S, Abubakr Y, et al, American Society of Clinical Oncology, 1/1/1999
• "Interim Analysis of a Non-Comparative, Multicenter Study of DOXIL/CAELYX in the Treatment of Patients with Refractory Ovarian Cancer."
  Rose P, Gordon A, Granai C, Hainsworth J, Weissman C, Lopez A, Kosty M, Peters W, Malfetano J, Malviya V, DelPrete S, Moore M, Wolin W, Goldberg D, Feherenbacher L, Ye..., American Society of Clinical Oncology, 1/1/1999
• "A Phase II Pilot Trial Evaluating Raltitrexed ('Tomudex') 4.0 mg/m2 as Second-and Third-Line Therapy in Patients with Metastatic Colorectal Cancer."
  Schulz J, Garfield D, et al, American Society of Clinical Oncology, 1/1/1999
• "Phase II Randomized Multicenter Trial of Two Dose Schedules of Gemcitabine as Second-line Therapy in Patients with Advanced Non-small Cell Lung Cancer (ANSCLC)."
  Garfield D, Dakhil S, et al, American Society of Clinical Oncology, 1/1/1998
• "Aminoglutethimidine in Metastatic Adenocarcinoma of the Prostate."
  Crawford E, Garfield D, et al, American Society of Clinical Oncology, 1/1/1984
• "Vindesine and cis-Platinum in the Treatment of Unresectable Carcinoma of the Lung."
  Pajon E, Garfield D, et al, American Society of Clinical Oncology, 1/1/1982
• "Combination Chemotherapy with BCNU, Vincristine, Mitomycin C, and Prednisone for Patients with Adenocarcinoma of the Breast Refractory to Conventional Agents."
  Garfield D, et al, American Society of Clinical Oncology, 1/1/1981
• Join now to see all

Lectures

• "Phase II comparative study of two dose schedules of gemcitabine (Gem) as second-line therapy in patients with advanced non-small cell lung cancer (ANSCLC)." 
  Paris, France - 2/3/1998

Other

• Monograph: "Molecular targeted therapy in oncology for the 21st century: bench to bedside." 
  Iwata KK, Haley JD, Garfield DH
  1/1/2006
• Bronchioloalveolar Carcinoma (BAC): New insights in epidemiology, pathology, and novel strategies. 
  West H(J), Garfield D, Lung Cancer, Principles and Practice, publisher: Lippincott Williams @ Wilkins, vol. 3
  1/1/2004